JESSICA LEVY: Open Payments
NPI 1790253821 · AVENTURA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,595 in 68 payments from 20 companies in 2025. Trend: 2023 $1,500 · 2024 $1,366 · 2025 $1,595
Food & beverage: $1,595
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $354 |
| Novartis Pharmaceuticals Corporation | 6 | $250 |
| Novo Nordisk Inc | 5 | $204 |
| Amgen Inc. | 15 | $198 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $91 |
| Ardelyx, Inc. | 3 | $67 |
| GlaxoSmithKline, LLC. | 3 | $66 |
| Lilly USA, LLC | 3 | $59 |
| PFIZER INC. | 2 | $51 |
| DePuy Synthes Sales Inc. | 2 | $31 |
Products named: AIRSUPRA, LEQVIO, EVENITY, JARDIANCE, OTEZLA, IBSRELA, Ozempic, FARXIGA.
Industry payments across FL — which companies pay providers there.
